Secondary cancers, comorbidities and mortality associated with nitrogen mustard therapy in patients with mycosis fungoides: a 30-year population-based cohort study-Reference-Cited by-同舟云学术

Secondary cancers, comorbidities and mortality associated with nitrogen mustard therapy in patients with mycosis fungoides: a 30-year population-based cohort study

Published:2014-03 Issue:3 Volume:170 Page:699-704
ISSN:0007-0963
Container-title:British Journal of Dermatology
language:en
Short-container-title:Br J Dermatol

Author:

Lindahl L.M.¹,Fenger-Grøn M.²,Iversen L.¹

Affiliation:

1. Department of Dermatology; Aarhus University Hospital; Aarhus Denmark

2. Department of Clinical Epidemiology; Aarhus University Hospital and Research Unit for General Practice; Aarhus University; Aarhus Denmark

Publisher

Wiley

Subject

Dermatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjd.12620/fullpdf

Reference36 articles.

1. The pathogenesis of mycosis fungoides;Girardi;N Engl J Med,2004

2. Mycosis fungoides and the Sézary syndrome: a review of pathogenesis, diagnosis, and therapy;Kuzel;J Clin Oncol,1991

3. EORTC classification for primary cutaneous lymphomas: a proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer;Willemze;Blood,1997

4. Treatment of cutaneous T cell lymphoma: current status and future directions;Apisarnthanarax;Am J Clin Dermatol,2002

5. WHO-EORTC classification for cutaneous lymphomas;Willemze;Blood,2005

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Melanoma as Subsequent Primary Malignancy in Hematologic Cancer Survivors—A Literature Review;Journal of Clinical Medicine;2024-08-01

2. Chlormethine gel in combination with other therapies for treatment of mycosis fungoides: a review with patient cases;Frontiers in Medicine;2024-01-11

3. Nitrogen mustards;Encyclopedia of Toxicology;2024

4. EORTC consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome – Update 2023;European Journal of Cancer;2023-12

5. Mechlorethamine Hydrochloride Gel in the Treatment of Mycosis Fungoides–Type Cutaneous T-Cell Lymphoma (MF-CTCL): A Focus on Patient Selection and Special Considerations;Cancer Management and Research;2022-11